Atlas Trials

Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients

Clinical trial NCT02165761 · TERMINATED

Trial details

NCT number
NCT02165761
Sponsor
W.L.Gore & Associates
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2014-07-01
Primary completion
2017-01-20
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.